11727410

Source:http://linkedlifedata.com/resource/pubmed/id/11727410

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0019699, umls-concept:C0027361, umls-concept:C0035647, umls-concept:C0087111, umls-concept:C0237506, umls-concept:C0282425, umls-concept:C0443239, umls-concept:C0683598, umls-concept:C1314939
pubmed:issue	6
pubmed:dateCreated	2001-11-30
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9614441
pubmed:citationSubset	X
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Anti-HIV Agents
pubmed:status	MEDLINE
pubmed:month	Nov
pubmed:issn	1551-8396
pubmed:author	pubmed-author:GallantJ EJE
pubmed:issnType	Print
pubmed:volume	13
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	10
pubmed:dateRevised	2004-11-17
pubmed:meshHeading	pubmed-meshheading:11727410-Anti-HIV Agents, pubmed-meshheading:11727410-CD4 Lymphocyte Count, pubmed-meshheading:11727410-Drug Administration Schedule, pubmed-meshheading:11727410-HIV Infections, pubmed-meshheading:11727410-Humans, pubmed-meshheading:11727410-Viral Load
pubmed:year	2001
pubmed:articleTitle	What is the latest news on structured interrupted treatment? Should a healthy HIV positive person consider an STI? What are the risks involved and for how long should the meds be interrupted? Is there any chance of developing resistance?
pubmed:publicationType	Newspaper Article